The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026
EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

Erik Sahai, Principal Group Leader and Deputy Research Director at the Francis Crick Institute, travelled to Nanchang, China, this month to deliver an EACR keynote talk titled “The Cell Biology of Tumour-Stroma Boundaries” at the the Chinese Society for Cell Biology’s 7th National Annual Conference on Tumour Cell Biology.

Keynote speaker, Erik Sahai

Reflecting on the trip shortly after returning, Erik noted the high scientific standard at the meeting, and that he was fortunate to have his travel rebooked at short notice when a typhoon threatened to hit Shanghai!

Alongside his keynote, Erik took part in a journal session at the conference (“Authors Ask, Editors Answer”), representing the Journal of Cell Biology and the Journal of Cell Science.

Erik’s Tumour Cell Biology Laboratory at the Crick studies how cancer spreads through the body and becomes resistant to treatment – processes strongly shaped by the interplay between tumour cells and the surrounding non-cancerous cells. The group combines patient data with experimental models, live imaging of tumours in real time, and computational modelling of the molecular dialogue between between different cells within a tumour, aiming to uncover new ways to predict metastasis and identify potential treatment targets.

Many thanks to Erik for representing the EACR beyond Europe. ✈️

Tags: EACR Members

Related Posts

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”:  Peijin Jiang’s Travel Fellowship

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”: Peijin Jiang’s Travel Fellowship

September 23, 2026

Peijin Jiang is a PhD student at the Vall d’Hebrón Institute of Oncology (VHIO), Spain, who received an EACR Travel Fellowship to visit and work at...

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

September 11, 2026

" provided practical insights into leadership, communication, negotiation, and career development that directly align with the challenges of establishing and leading an independent multidisciplinary research program....

Virtual conferences are no longer a compromise: What six years of data reveals

Virtual conferences are no longer a compromise: What six years of data reveals

October 6, 2026

When the EACR ran its first virtual conferences in 2020, it was a decision made to address the quickly evolving Covid-19 crisis. International travel was near...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution
News

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution

October 8, 2026
VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms
News

VIDEO | The Evolving ADC Landscape: From Monotherapies to Rational Combinations and Next-Generation Platforms

October 1, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR